Related Experiment Videos
Major locus influencing plasma APO-A1 levels also controls plasma HDL3-C concentrations
G Livshits1, M Vainder, M Blettner
1Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel Aviv University, Israel. gregl@ccsg.tau.ac.il
Insights
Apolipoprotein A1 (APO-A1) major locus significantly influences high-density lipoprotein cholesterol (HDL-C) levels, particularly HDL3-C. This finding supports a key genetic link between APO-A1 and HDL3-C, impacting cardiovascular health.
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Biochemistry
Background:
- Elevated apolipoprotein A1 (APO-A1) and high-density lipoprotein cholesterol (HDL-C) are crucial protective factors against atherosclerosis and coronary heart disease.
- Understanding the genetic underpinnings of these lipid levels is vital for developing targeted interventions.
Purpose of the Study:
- To investigate whether a major genetic locus influencing apolipoprotein A1 (APO-A1) plasma levels also controls variations in HDL3-C and HDL2-C levels.
- To determine the genetic relationship between APO-A1 and HDL-C subfractions.
Main Methods:
- Utilized data from 970 Israeli individuals across 228 pedigrees.
- Applied univariate and bivariate complex segregation analyses using MAN-3 and PAP-4.0 statistical packages.
- Tested hypotheses regarding major gene involvement and pleiotropic effects.
Main Results:
- Strong evidence supports a major gene locus for APO-A1 that also determines HDL3-C variation.
- Environmental and sporadic models were rejected (P < 0.001) in bivariate analysis.
- The pleiotropic effect of the APO-A1 locus on HDL3-C transmission was confirmed (P < 0.001), with a bivariate Mendelian model accepted (P > 0.05).
- Results for APO-A1's effect on HDL2-C were inconclusive, suggesting possible minor genetic covariation.
Conclusions:
- A major genetic locus significantly influences both APO-A1 and HDL3-C plasma concentrations, indicating a strong genetic link.
- This locus plays a critical role in the genetic determination of HDL3-C levels.
- The genetic control of HDL2-C by the APO-A1 locus remains unclear, warranting further investigation.
Abstract:
Elevated plasma levels of apolipoprotein A1 (APO-A1) and high-density lipoprotein cholesterol (HDL-C) are important protective factors for atherosclerosis and coronary heart disease. Using the data on plasma concentrations of APO-A1, and HDL-C particles HDL2-C and HDL3-C in 970 Israeli individuals belonging to 228 pedigrees, we tested the hypothesis that a major locus influencing interindividual variation in APO-A1 levels also controls interindividual variation in HDL3-C and HDL2-C levels. Univariate and bivariate complex segregation analyses, as implemented in two statistical packages (MAN-3 and PAP-4.0) were applied to test the hypothesis. The results of the analysis clearly indicated the possibility of major gene involvement in the determination of plasma concentration variation of each of the 3 study variables. The results provide strong evidence in support of our hypothesis that HDL3-C genetic variation fully depends on the APO-A1 major locus. In particular, environmental and sporadic models were strongly rejected (P < 0.001) in bivariate analysis. The hypothesis of no pleiotropic effect of the putative APO-A1 locus on HDL3-C transmission was also unequivocally rejected (P < 0.001), while the bivariate Mendelian model was accepted (P > 0.05). The results of bivariate analysis of APO-A1 effect on HDL2-C were not clear. They indicated the possibility of the existence of slight genetic covariation between the two variables, and as yet we were unable to decipher the mode of covariation with the applied models.